Literature DB >> 7726385

Comparative frequency and severity of hypoglycemia in selected organic acidemias, branched chain amino acidemia, and disorders of fructose metabolism.

H G Worthen1, A al Ashwal, P T Ozand, S Garawi, Z Rahbeeni, A al Odaib, S B Subramanyam, M Rashed.   

Abstract

The Institution's experience with hypoglycemia in different types of organic acidemias, branched chain amino acidemia (MSUD), and disorders of fructose metabolism was reviewed retrospectively. The charts of 144 patients who were followed for 1-5 years were studied for the severity and frequency of hypoglycemia. The patients were mainly Saudi; however, 10-25% were from neighboring countries. Therefore, the observations pertain to the genetic groups in the Arabian peninsula. Organic acidemias which primarily manifest with neurologic signs, such as 4-hydroxybutyric aciduria, infantile onset 3-methylglutaconic aciduria, and glutaric aciduria type 1 never showed hypoglycemia. Patients with beta-ketothiolase deficiency, biotinidase deficiency, or intermittent or intermediate MSUD, also did not have hypoglycemia during metabolic crisis. Hypoglycemia was rare and mild among neonates with classic MSUD, ethylmalonic aciduria, and isovaleric acidemia. Less than 50% of the patients with MSUD older than 8 months, pyruvate carboxylase deficiency, methylmalonic acidemia, or propionic acidemia had hypoglycemia during metabolic crisis. On the other hand, patients with 3-hydroxy-3-methyl glutaryl-CoA lyase deficiency, holocarboxylase synthetase deficiency, medium or long-chain acyl-CoA dehydrogenase deficiency, neonatal onset 3-methylglutaconic aciduria, glutaric aciduria type 2, and disorders of fructose metabolism invariably had moderate-to-severe hypoglycemia associated with metabolic crisis. The purpose of this report is to provide the pediatrician, particularly in the Middle East, with a diagnostic guideline to the identification and management of different types of organic acidemias, based on co-existing hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7726385     DOI: 10.1016/0387-7604(94)90100-7

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  8 in total

1.  Lactate dehydrogenase activity is inhibited by methylmalonate in vitro.

Authors:  Laura O Saad; Sandra R Mirandola; Evelise N Maciel; Roger F Castilho
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

2.  Acute decompensation of isovaleric acidemia induced by Graves' disease.

Authors:  Antoine Kimmoun; Georges Abboud; Jean Strazeck; Marc Merten; Jean-Louis Guéant; François Feillet
Journal:  Intensive Care Med       Date:  2008-07-08       Impact factor: 17.440

3.  Isovaleric acidemia appearing as diabetic ketoacidosis.

Authors:  N Attia; N Sakati; A al Ashwal; R al Saif; M Rashed; P T Ozand
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Defect of cobalamin intracellular metabolism presenting as diabetic ketoacidosis: a rare manifestation.

Authors:  Sheetal Sharda; Suresh Kumar Angurana; Mandeep Walia; Savita Attri
Journal:  JIMD Rep       Date:  2013-04-02

Review 5.  Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity.

Authors:  Jerry Vockley; Regina Ensenauer
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

Review 6.  Neurological dysfunction in methylmalonic acidaemia is probably related to the inhibitory effect of methylmalonate on brain energy production.

Authors:  M Wajner; J C Coelho
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

7.  Insulin-resistant hyperglycaemia complicating neonatal onset of methylmalonic and propionic acidaemias.

Authors:  L Filippi; E Gozzini; C Cavicchi; A Morrone; P Fiorini; G Donzelli; S Malvagia; G la Marca
Journal:  J Inherit Metab Dis       Date:  2009-07-09       Impact factor: 4.982

8.  Novel FBP1 gene mutations in Arab patients with fructose-1,6-bisphosphatase deficiency.

Authors:  Muhammad Faiyaz-Ul-Haque; Mohammed Al-Owain; Fouad Al-Dayel; Zuhair Al-Hassnan; Hamad Al-Zaidan; Zuhair Rahbeeni; Moeen Al-Sayed; Ameera Balobaid; Ahmad Cluntun; Mohamed Toulimat; Hala Abalkhail; Iskra Peltekova; Syed H E Zaidi
Journal:  Eur J Pediatr       Date:  2009-03-04       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.